Comparative Pharmacology
Head-to-head clinical analysis: DURAGESIC 25 versus JOBEVNE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DURAGESIC 25 versus JOBEVNE.
DURAGESIC-25 vs JOBEVNE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fentanyl is a mu-opioid receptor agonist that produces analgesia and sedation by mimicking endogenous opioids in the central nervous system.
JOBEVNE is a monoclonal antibody that binds to and inhibits the activity of a specific cytokine receptor, reducing inflammatory signaling.
Apply 25 mcg/hour transdermally every 72 hours; initial dose in opioid-naive patients: 25 mcg/hour is not recommended; use lower strength or immediate-release opioid first.
100 mg intravenously every 12 hours.
None Documented
None Documented
Terminal elimination half-life 22-25 hours (range 13-31 h) after 72-h transdermal application; prolonged in elderly, hepatic or renal impairment
Terminal half-life: 12-15 hours; clinical context: supports twice-daily dosing in most patients
Renal (75% as metabolites, <10% unchanged); fecal (9%)
Renal: 60% unchanged; biliary/fecal: 30% as metabolites; 10% other
Category C
Category C
Opioid Analgesic
Opioid Analgesic